Sammaan Capital Q2 FY27: Flat Consolidated PAT Hides ~68% Adjusted Profit Decline
PAT +1.25% YoY · revenue -17.8% · margins expanding · inline vs street
₹1,849.97 Cr
-17.8% YoY
₹312.34 Cr
+1.25% YoY
16.88%
+3.2pp YoY
₹2.72
Sammaan Capital (formerly Indiabulls Housing Finance) reported consolidated PAT of ₹312.34 Cr for Q2 FY27, up just 1.3% YoY from ₹308.47 Cr and up 28.4% QoQ from ₹243.30 Cr, even as consolidated revenue from operations fell 17.8% YoY to ₹1,849.97 Cr (from ₹2,250.60 Cr) while rising 12.0% QoQ. The YoY PAT stability is misleading: stripping out the swing in the impairment line, pre-tax profit from core operations would have fallen roughly 68% YoY (an estimated ₹207.91 Cr versus ₹654.06 Cr a year ago, after tax ~₹152.9 Cr versus ~₹474.7 Cr) — this was a quarter kept in the black by a credit-cost reversal, not operating improvement.
Q2 FY-2027 vs prior quarters
Consolidated net profit margin expanded to 16.9% of total income from 13.65% YoY and 14.46% QoQ, but the expansion traces entirely to 'impairment on financial instruments (net of recoveries/written back)' swinging to a ₹216.66 Cr credit this quarter from a ₹229.03 Cr charge in Q2 FY26 — a ₹445.69 Cr favorable swing that offset the topline decline. That topline decline was itself driven by 'net gain on derecognition of financial instruments' collapsing to ₹7.19 Cr from ₹468.81 Cr a year ago, as last year's Identified-Exposures reclassification/ARC-sale-linked income recognition normalized. Interest income also fell YoY, to ₹1,161.26 Cr from ₹1,449.02 Cr, despite the standalone loan book growing to ₹40,935.69 Cr (from ₹33,914.56 Cr at March-26) — a yield or asset-mix shift the filing does not itself explain.
The stock went into the print at ₹137.52, up 3.6% over the past month of trading.
For context: PAT has now risen for 2 consecutive quarters.
What the summary numbers don't show
Basic EPS ₹2.72 (consolidated) vs ₹2.13 last quarter and ₹3.79 a year ago — paid-up equity capital rose to ₹229.34 Cr from ₹162.70 Cr YoY on Avenir's preferential allotment/warrant conversions.
Management expects to become a full-suite NBFC post the IHC investment and the merger of Sammaan Finserve, aiming to expand product offerings to mid-market to low-income India. The company plans to rapidly expand its branch network and leverage its technology platform. Long-term targets include increasing leverage to 4
Against our pre-result preview (PAT ₹300–500 Cr, annualized ROA 1.6–1.8% expected), the quarter is in-line but at the bottom of the range: PAT of ₹312.34 Cr annualizes to an ROA of ~1.72% on ₹72,556.36 Cr of consolidated assets, inside the expected band, and disbursements (~₹6,000 Cr) and AUM (~₹59,000 Cr) both matched the company's own prior business update. But the preview framed this quarter as a test of whether PAT inflection was genuine rather than loan-growth- or accounting-driven — the impairment-reversal dependency argues it is not yet proven. Management gave no quarter-specific guidance in this filing or press release (only the procedural board-outcome letter was available); the Feb-2026 concall's targets — 4x–4.5x leverage by 2030, 100bps core-mortgage credit cost, ~270bps cost-of-funds reduction by March 2027 — are multi-year and not verifiable off a single quarter. Standalone PAT of ₹341.96 Cr (+24.1% YoY) diverges sharply from the consolidated +1.3% YoY print; the ₹29.62 Cr gap is fully explained by a net loss at the Group's nine subsidiaries and trust this quarter, so the core lending entity performed better than the group number suggests. Concurrently, Avenir Investment RSC sold a 6.94% stake even as it was separately allotted 8.68 Cr shares via warrant conversion, and the NCLT has fixed November 16, 2026 as the next hearing date for the Sammaan Finserve merger scheme.
W1
Credit-cost normalization: two straight quarters of impairment write-backs (₹240.47 Cr Q1, ₹216.66 Cr Q2 FY27) have supported profit — a reversal would expose the ~68% adjusted YoY profit decline.
W2
Cost of funds progress toward management's ~270bps reduction target by March 2027, contingent on the IHC investment process completing.
W3
Sammaan Finserve merger scheme: NCLT has fixed November 16, 2026 as the next hearing date.
Informational and educational content only. Not investment advice.